Milnacipran: A Unique Antidepressant?

Neuropsychiatric Disease and Treatment - New Zealand
doi 10.2147/ndt.s11777
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Savella® (Milnacipran) Causing Elevated Normetanephrines

Kansas Journal of Medicine
2019English

Editorial Foreword - Milnacipran: Recent Findings in Depression

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Determination of Milnacipran in Serum by LC/MS

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2005English

Milnacipran for Neuropathic Pain and Fibromyalgia in Adults

2010English

Continuing Efficacy of Milnacipran Following Long-Term Treatment in Fibromyalgia: A Randomized Trial

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

Comparative Trial of a New Antidepressant

British Journal of Psychiatry
MedicinePsychiatryMental Health
1987English

BDNF – A Key Transducer of Antidepressant Effects

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2016English

Tricyclic Antidepressant Poisoning.

BMJ
1979English

Is a Polygenic Predictor of Antidepressant Response a Possibility?

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy